Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di S Regulatory News (MYXR)

  • There is currently no data for MYXR

Trading Update

11 Dec 2015 07:00

RNS Number : 7138I
MyCelx Technologies Corporation
11 December 2015
 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)("MYCELX" or the "Company")

Trading Update

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces a trading update on its 2015 revenue and financial performance.

 

MYCELX has continued with its cost reduction measures and consequently, in line with the Company's previous guidance, the Company confirms that it will be at least cash neutral from operations in H2 2015. Net cash at year is expected to be not less than $3.7 million.

The Company now expects to report full year revenue for FY2015 that will be in line with that for FY2014, and will be in the region of $13.5 - 13.8 million (FY2014: $13.581 million). In response to continued weakening of the oil price during H2 2015, MYCELX's customers have increased focus on their own cost management and reduced their purchases of MYCELX media impacting the Company's ability to sustain its forecasted run rate.

The reduction in revenue is expected to result in a post-tax loss in the region of $3.4 - 3.8 million. The substantial reduction in the net loss of approximately 40% compared to FY2014 ($5.920m) is due to the cost reductions implemented by the Company in response to the current market conditions and which have been continuously monitored during H2 2015.

The Company will provide guidance on its revenue expectation for FY2016 in due course.

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, Interim CFO

 

 

Tel: +1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Jonathan Stephens

 

Corporate Broking

Jonathan Williams

Kim Eckhof

 

Tel: +44 20 3440 6800

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

 

Tel: +44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

 

Tel: +44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKKDNPBDDFBD
Date   Source Headline
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change
15th Apr 20132:18 pmRNSHolding(s) in Company
26th Mar 20135:21 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNS2012 Preliminary Results
18th Feb 201312:09 pmRNSTransfer of MyCelx Shares between lines of stock
3rd Jan 20137:00 amRNSIssue of Equity/Total Voting Rights
12th Nov 20129:52 amRNSTransfer of MyCelx Shares between lines of stock
8th Oct 20124:11 pmRNSTransfer of MyCelx Shares between lines of stock
13th Sep 20127:00 amRNSAppointment of CFO and Board Director
30th Aug 20127:00 amRNSMyCelx Shares to be Traded on CREST
14th Aug 20127:01 amRNSWebcast interview with CEO
14th Aug 20127:00 amRNSHalf Year Results
8th Aug 20127:00 amRNSContract Win for US$2.35 Million
31st May 20127:00 amRNSRe Contract
10th May 201211:02 amRNSResult of Annual Meeting/Grant of Share Option
9th May 20127:00 amRNSTrading Statement
23rd Apr 20127:00 amRNSPurchase Orders Received for US$2.65 million
17th Apr 20125:34 pmRNSAnnual Financial Report
6th Mar 20127:00 amRNS2011 Preliminary Results
27th Feb 20127:00 amRNSNotice of Preliminary Results
9th Jan 20127:00 amRNSNon-Executive Director Appointment
21st Dec 201110:10 amRNSAccident at Gainesville R&D Site
1st Nov 201112:01 pmRNSPurchase Order Update
1st Nov 20117:00 amRNSPurchase Order and Business Update
27th Sep 20117:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.